Multimodal in vivo and postmortem assessments of tau in Lewy body disorders
- PMID: 33002767
- PMCID: PMC7819484
- DOI: 10.1016/j.neurobiolaging.2020.08.003
Multimodal in vivo and postmortem assessments of tau in Lewy body disorders
Abstract
We compared regional retention of 18F-flortaucipir between 20 patients with Lewy body disorders (LBD), 12 Alzheimer's disease patients with positive amyloid positron emission tomography (PET) scans (AD+Aβ) and 15 healthy controls with negative amyloid PET scans (HC-Aβ). In LBD subjects, we compared the relationship between 18F-flortaucipir retention and cerebrospinal fluid (CSF) tau, cognitive performance, and neuropathological tau at autopsy. The LBD cohort was stratified using an Aβ42 cut-off of 192 pg/mL to enrich for groups likely harboring tau pathology (LBD+Aβ = 11, LBD-Aβ = 9). 18F-flortaucipir retention was higher in LBD+AB than HC-Aβ in five, largely temporal-parietal regions with sparing of medial temporal regions. Higher retention was associated with higher CSF total-tau levels (p = 0.04), poorer domain-specific cognitive performance (p = 0.02-0.04), and greater severity of neuropathological tau in corresponding regions. While 18F-flortaucipir retention in LBD is intermediate between healthy controls and AD, retention relates to cognitive impairment, CSF total-tau, and neuropathological tau. Future work in larger autopsy-validated cohorts is needed to define LBD-specific tau biomarker profiles.
Keywords: CSF; Cognition; Lewy body diseases; Neuropathology; PET imaging; Tau.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Potential Conflicts of Interest
Andrew Siderowf was a full time employee of AVID radiopharmaceuticals from July 2012 to June 2017.
Figures
References
-
- Baldo JV, Shimamura AP, 1998. Letter and category fluency in patients with frontal lobe lesions. Neuropsychology 12(2), 259–267. - PubMed
-
- Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WA, 2007. The National Alzheimer’s Coordinating Center (NACC) database: the uniform data set. Alzheimer Dis. Assoc. Disord. 21(3), 249–258. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 AG010124/AG/NIA NIH HHS/United States
- P01 AG017586/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- P30 AG062429/AG/NIA NIH HHS/United States
- P50 NS053488/NS/NINDS NIH HHS/United States
- U19 AG024904/AG/NIA NIH HHS/United States
- R56 AG058732/AG/NIA NIH HHS/United States
- CIHR/Canada
- P01 AG066597/AG/NIA NIH HHS/United States
- U19 AG062418/AG/NIA NIH HHS/United States
- TL1 TR001880/TR/NCATS NIH HHS/United States
- K01 AG061277/AG/NIA NIH HHS/United States
- R01 NS109260/NS/NINDS NIH HHS/United States
- R01 AG054519/AG/NIA NIH HHS/United States
- K23 NS088341/NS/NINDS NIH HHS/United States
